Nahoko Kaniwa

Nahoko Kaniwa

UNVERIFIED PROFILE

Are you Nahoko Kaniwa?   Register this Author

Register author
Nahoko Kaniwa

Nahoko Kaniwa

Publications by authors named "Nahoko Kaniwa"

Are you Nahoko Kaniwa?   Register this Author

68Publications

1059Reads

27Profile Views

Low Levels of Amlodipine in Breast Milk and Plasma.

Breastfeed Med 2018 11 28;13(9):622-626. Epub 2018 Sep 28.

8 Division of Clinical Pharmacology and Toxicology, Hospital for Sick Children , Toronto, Ontario, Canada .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/bfm.2018.0158DOI Listing
November 2018

[Utilization of Genomic Biomarkers for Post-marketing Safety of Drugs].

Authors:
Nahoko Kaniwa

Yakugaku Zasshi 2015 ;135(5):671-9

Division of Medicinal Safety Science, National Institute of Health Sciences.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1248/yakushi.14-00230-4DOI Listing
September 2016

[Biomarker exploration and its clinical use].

Yakugaku Zasshi 2013 ;133(12):1373-9

Division of Medicinal Safety Science, National Institute of Health Sciences.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1248/yakushi.13-00232-2DOI Listing
July 2014

Genetic factors associated with gemcitabine pharmacokinetics, disposition, and toxicity.

Pharmacogenet Genomics 2014 Jan;24(1):15-25

aDepartment of Pharmaceutical Sciences, State University of New York, Buffalo, New York, USA bClinical Research Center, Chiba University School of Medicine, Chiba cDivision of Medicinal Safety Science, National Institute of Health Sciences dHepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/jpharmacogenetics/2014/01000/Ge
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/FPC.0000000000000016DOI Listing
January 2014

Identification of a candidate single-nucleotide polymorphism related to chemotherapeutic response through a combination of knowledge-based algorithm and hypothesis-free genomic data.

J Biosci Bioeng 2013 Dec 29;116(6):768-73. Epub 2013 Jun 29.

Graduate School of Horticulture, Chiba University, 648 Matsudo, Matsudo, Chiba 271-8510, Japan; Plant Biology Research Center, Chubu University, Matsumoto-cho 1200, Kasugai, Aichi 487-8501, Japan; Division of Genetics, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jbiosc.2013.05.021DOI Listing
December 2013

The risk of cutaneous adverse reactions among patients with the HLA-A* 31:01 allele who are given carbamazepine, oxcarbazepine or eslicarbazepine: a perspective review.

Ther Adv Drug Saf 2013 Dec;4(6):246-53

Director, Division of Medicinal Safety Science, National Institute of Health Sciences, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2042098613499791DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4125310PMC
December 2013

Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.

J Hum Genet 2013 Jun 2;58(6):317-26. Epub 2013 May 2.

Division of Medicinal Safety Science, National Institute of Health Sciences, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/jhg.2013.37DOI Listing
June 2013

Pharmacogenomics of severe cutaneous adverse reactions.

Pharmacogenomics 2013 Apr;14(6):595-8

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs.13.27DOI Listing
April 2013

[Current movements of four serious adverse events induced by medicinal drugs based on spontaneous reports in Japan].

Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku 2011 (129):111-7

Division of Medicinal Safety Science, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501 Japan.

View Article

Download full-text PDF

Source
February 2012

[Exploratory study on biomarkers associated with severe cutaneous adverse reactions].

Authors:
Nahoko Kaniwa

Yakugaku Zasshi 2011 Feb;131(2):255-61

Division of Medicinal Safety Science, National Institute of Health Sciences, Tokyo.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1248/yakushi.131.255DOI Listing
February 2011

Prediction of severe adverse drug reactions using pharmacogenetic biomarkers.

Drug Metab Pharmacokinet 2010 ;25(2):122-33

National Institute of Health Sciences, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://ac.els-cdn.com/S1347436715300148/1-s2.0-S134743671530
Web Search
August 2010

[Exploratory studies on genetic biomarkers related to serious drug adverse reactions].

Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku 2009 (127):1-14

View Article

Download full-text PDF

Source
June 2010

Ethnic differences of two non-synonymous single nucleotide polymorphisms in CDA gene.

Drug Metab Pharmacokinet 2009 ;24(6):553-6

Project Team for Pharmacogenetics, National Institute of Health Sciences, Tokyo 158-8501, Japan.

View Article

Download full-text PDF

Source
April 2010

HLA class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions.

Epilepsia 2010 Feb 19;51(2):297-300. Epub 2009 Aug 19.

National Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders, Shizuoka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1528-1167.2009.02269.xDOI Listing
February 2010

Substrate-dependent functional alterations of seven CYP2C9 variants found in Japanese subjects.

Drug Metab Dispos 2009 Sep 18;37(9):1895-903. Epub 2009 Jun 18.

Division of Functional Biochemistry and Genomics, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/dmd.109.027003DOI Listing
September 2009

Importance of UDP-glucuronosyltransferase 1A1*6 for irinotecan toxicities in Japanese cancer patients.

Cancer Lett 2008 Mar 20;261(2):165-71. Epub 2007 Dec 20.

Division of Biosignaling, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S030438350700554
Publisher Site
http://dx.doi.org/10.1016/j.canlet.2007.11.009DOI Listing
March 2008

Effect of CYP2C9 genetic polymorphisms on the efficacy and pharmacokinetics of glimepiride in subjects with type 2 diabetes.

Diabetes Res Clin Pract 2006 May 1;72(2):148-54. Epub 2005 Dec 1.

Department of Pharmacy, Nerima General Hospital, Tokyo 176-8530, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.diabres.2005.09.019DOI Listing
May 2006

Genetic variation and haplotype structure of the ABC transporter gene ABCG2 in a Japanese population.

Drug Metab Pharmacokinet 2006 Apr;21(2):109-21

Project Team for Pharmacogenetics, Division of Biochemistry and Immunochemistry, National Institute of Health Sciences, Kamiyoga, Tokyo, Japan.

View Article

Download full-text PDF

Source
April 2006

Haplotype analysis of ABCB1/MDR1 blocks in a Japanese population reveals genotype-dependent renal clearance of irinotecan.

Pharmacogenetics 2003 Dec;13(12):741-57

Project Team for Pharmacogenetics, Division of Xenobiotic Metabolism and Disposition, National Institute of Health Sciences, 1-18-1, Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.fpc.0000054137.14659.f7DOI Listing
December 2003

Comprehensive UGT1A1 genotyping in a Japanese population by pyrosequencing.

Clin Chem 2003 Jul;49(7):1182-5

Project Team for Pharmacogenetics, Division of Biochemistry and Immunochemistry, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan.

View Article

Download full-text PDF

Source
http://clinchem.aaccjnls.org/content/49/7/1182.full.pdf
Web Search
July 2003

Cytosolic and microsomal activation of doxifluridine and tegafur to produce 5-fluorouracil in human liver.

Cancer Chemother Pharmacol 2002 Dec 26;50(6):454-8. Epub 2002 Oct 26.

Project Team for Pharmacogenetics, National Institute of Health Sciences, Kamiyoga, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-002-0528-1DOI Listing
December 2002